EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Large‐scale deep proteomic analysis in Alzheimer's disease brain regions across race and ethnicity

Fatemeh Seifar, Edward J Fox, Anantharaman Shantaraman, Yue Liu, Eric B Dammer, Erica Modeste, Duc M Duong, Luming Yin, Adam N Trautwig, Qi Guo, Kaiming Xu, Lingyan Ping und 38 weitere

Alzheimer's & Dementia · 2024

DOI: 10.1002/alz.14360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Fatemeh Seifar und 49 weiteren Autor:innen. Beteiligte Einrichtung: Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Brain, Proteomics. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, BLRD VA, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Alzheimer's disease (AD) is the most prevalent neurodegenerative disease, yet our comprehension predominantly relies on studies within non‐Hispanic White (NHW) populations. Here we provide an extensive survey of the proteomic landscape of AD across diverse racial/ethnic groups. METHODS Two cortical regions, from multiple centers, were harmonized by uniform neuropathological diagnosis. Among 998 unique donors, 273 donors self‐identified as African American, 229 as Latino American, and 434 as NHW. RESULTS While amyloid precursor protein and the microtubule‐associated protein tau demonstrated higher abundance in AD brains, no significant race‐related differences were observed. Further proteome‐wide and focused analyses (specific amyloid beta [Aβ] species and the tau domains) supported the absence of racial differences in these AD pathologies within the brain proteome. DISCUSSION Our findings indicate that the racial differences in AD risk and clinical presentation are not underpinned by dramatically divergent patterns in the brain proteome, suggesting that other determinants account for these clinical disparities. Highlights We present a large‐scale proteome (∼10,000 proteins) of DLPFC (998) and STG (244) across AD cases. About 50% of samples were from racially and ethnically diverse brain donors. Key AD proteins (amyloid and tau) correlated with CERAD and Braak stages. No significant race‐related differences in amyloid and tau protein levels were observed in AD brains. AD‐associated protein changes showed a strong correlation between the brain proteomes of African American and White individuals. This dataset advances understanding of ethnoracial‐specific AD pathways and potential therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBrainProteomicsAgedAged, 80 and overFemaleHumansMaleAmyloid beta-PeptidesBlack or African AmericanEthnicityHispanic or LatinoProteometau ProteinsWhite

Stichwörter der Autor:innen

Alzheimer's diseasedata descriptordiversityprecision medicineproteomeproteomics

Substanzen

Amyloid beta-PeptidesProteometau Proteins

Autor:innen und Institutionen

  • Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida, USA.
  • Sage Bionetworks, Seattle, Washington, USA.
  • Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Mount Sinai Center for Transformative Disease Modeling, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • New York Genome Center, New York, New York, USA.

Förderung

  • NIA NIH HHS
  • BLRD VA
  • NINDS NIH HHS
  • National Institute on Aging

Zitieren

APA

Seifar, F., Fox, E. J., Shantaraman, A., Liu, Y., Dammer, E. B., Modeste, E., Duong, D. M., Yin, L., Trautwig, A. N., Guo, Q., Xu, K., Ping, L., Reddy, J. S., Allen, M., Quicksall, Z., Heath, L., Scanlan, J., Wang, E., Wang, M., …, & Seyfried, N. T. (2024). Large‐scale deep proteomic analysis in Alzheimer's disease brain regions across race and ethnicity. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14360

Vancouver

Seifar F, Fox EJ, Shantaraman A, Liu Y, Dammer EB, Modeste E, et al. Large‐scale deep proteomic analysis in Alzheimer's disease brain regions across race and ethnicity. Alzheimer's & Dementia. 2024. doi:10.1002/alz.14360

BibTeX
@article{Seifar2024,
  author = {Seifar, Fatemeh and Fox, Edward J and Shantaraman, Anantharaman and Liu, Yue and Dammer, Eric B and Modeste, Erica and Duong, Duc M and Yin, Luming and Trautwig, Adam N and Guo, Qi and Xu, Kaiming and Ping, Lingyan and Reddy, Joseph S and Allen, Mariet and Quicksall, Zachary and Heath, Laura and Scanlan, Jo and Wang, Erming and Wang, Minghui and Linden, Abby Vander and Poehlman, William and Chen, Xianfeng and Baheti, Saurabh and Ho, Charlotte and Nguyen, Thuy and Yepez, Geovanna and Mitchell, Adriana O and Oatman, Stephanie R and Wang, Xue and Carrasquillo, Minerva M and Runnels, Alexi and Beach, Thomas and Serrano, Geidy E and Dickson, Dennis W and Lee, Edward B and Golde, Todd E and Prokop, Stefan and Barnes, Lisa L and Zhang, Bin and Haroutunian, Varham and Gearing, Marla and Lah, James J and De Jager, Philip and Bennett, David A and Greenwood, Anna and Ertekin-Taner, Nilüfer and Levey, Allan I and Wingo, Aliza and Wingo, Thomas and Seyfried, Nicholas T},
  title = {Large‐scale deep proteomic analysis in Alzheimer's disease brain regions across race and ethnicity},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  doi = {10.1002/alz.14360}
}
Kostenlos starten →